Conference Presentation, Panel, Roundtable
The Future of Biomedical Research and Innovation | Future of Health Summit 2025
- The U.S. faces a critical "tipping point" where doubling down on scientific investments is deemed necessary to maintain leadership in economic growth and national security, countered by global competitors who are actively reducing U.S. capabilities while building their own.
- Failure to protect the talent pipeline, evidenced by a 30% reduction in graduate students at one School of Medicine and a drop in international lab applicants from 100–125 per month to two or three, risks a long-term negative impact on the biomedical ecosystem.
- Biomedical advancement must occur simultaneously with fixing the primary care system and non-biomedical health determinants to ensure broad access, avoiding a scenario where advanced biotechnology serves only the privileged 20 percent rather than the 80 percent majority.
- A "perfect storm" threatening the biomedical ecosystem carries the prediction of destroying 75 years of progress, while the global community is expected to make significant leaps and bounds beyond current U.S. levels within a one to three-year timeframe without waiting for U.S. coordination.
- A seven trillion dollar transfer of wealth is projected to occur over the next few years as baby boomers pass assets to younger generations with different philanthropic priorities, contingent on the preservation of tax incentives for foundations to avoid destroying the "golden goose."
- Proposed initiatives include a national life sciences strategy, a Data Counts program intended to become a major advancement in health data assessment, and a replicable rural medical education model from the Alice Walton School of Medicine.
- A 1% R&D implementation budget, potentially totaling $40 billion, is proposed to evaluate healthcare delivery effectiveness, alongside efforts by the Foundation for NIH to become an increasingly relevant part of the ecosystem despite a slow operational pace.